RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Medical System Holdings Stock

China Medical System Holdings Net Income 2024

China Medical System Holdings Net Income

1.79 B CNY

Ticker

867.HK

ISIN

KYG211081248

WKN

A1JLYP

In 2024, China Medical System Holdings's profit amounted to 1.79 B CNY, a -25.54% increase from the 2.4 B CNY profit recorded in the previous year.

The China Medical System Holdings Net Income history

YEARNET INCOME (undefined CNY)
2027e3.29
2026e2.64
2025e2.04
2024e1.79
20232.4
20223.26
20213.02
20202.53
20191.96
20181.85
20171.67
20161.38
20151
20141.05
20130.64
20120.54
20110.4
20100.21
20090.14
20080.1
20070.07
20060.03
20050.04
20040.03

China Medical System Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into China Medical System Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by China Medical System Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects China Medical System Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of China Medical System Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into China Medical System Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing China Medical System Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on China Medical System Holdings’s growth potential.

China Medical System Holdings Revenue, EBIT and net profit per share

DateChina Medical System Holdings RevenueChina Medical System Holdings EBITChina Medical System Holdings Net Income
2027e12.73 B undefined4 B undefined3.29 B undefined
2026e10.27 B undefined3.14 B undefined2.64 B undefined
2025e8.97 B undefined2.35 B undefined2.04 B undefined
2024e7.9 B undefined1.98 B undefined1.79 B undefined
20238.01 B undefined2.72 B undefined2.4 B undefined
20229.15 B undefined3.64 B undefined3.26 B undefined
20218.34 B undefined3.22 B undefined3.02 B undefined
20206.95 B undefined2.81 B undefined2.53 B undefined
20196.07 B undefined2.4 B undefined1.96 B undefined
20185.43 B undefined2.01 B undefined1.85 B undefined
20175.35 B undefined1.9 B undefined1.67 B undefined
20164.9 B undefined1.55 B undefined1.38 B undefined
20153.55 B undefined1.07 B undefined995.94 M undefined
20142.95 B undefined1.12 B undefined1.05 B undefined
20132.25 B undefined701.6 M undefined636.2 M undefined
20121.78 B undefined580.8 M undefined536.5 M undefined
20111.36 B undefined402.6 M undefined402.4 M undefined
2010894.6 M undefined237.8 M undefined207 M undefined
2009658.8 M undefined187.4 M undefined141.3 M undefined
2008504.5 M undefined128.4 M undefined103.9 M undefined
2007393.5 M undefined92.4 M undefined66 M undefined
2006300 M undefined44 M undefined32 M undefined
2005271.1 M undefined55.1 M undefined40 M undefined
2004227.3 M undefined48.2 M undefined29.6 M undefined

China Medical System Holdings stock margins

The China Medical System Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of China Medical System Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for China Medical System Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the China Medical System Holdings's sales revenue. A higher gross margin percentage indicates that the China Medical System Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the China Medical System Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the China Medical System Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the China Medical System Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the China Medical System Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the China Medical System Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

China Medical System Holdings Margin History

China Medical System Holdings Gross marginChina Medical System Holdings Profit marginChina Medical System Holdings EBIT marginChina Medical System Holdings Profit margin
2027e76.24 %31.4 %25.87 %
2026e76.24 %30.56 %25.73 %
2025e76.24 %26.2 %22.72 %
2024e76.24 %25.03 %22.64 %
202376.24 %33.89 %29.96 %
202276.89 %39.76 %35.62 %
202174.93 %38.59 %36.19 %
202073.92 %40.43 %36.43 %
201974.85 %39.58 %32.28 %
201872.09 %37.06 %34.05 %
201765.03 %35.46 %31.31 %
201659.42 %31.53 %28.08 %
201557.58 %30.11 %28.03 %
201456.18 %37.99 %35.51 %
201354.53 %31.2 %28.29 %
201258.82 %32.66 %30.17 %
201156.62 %29.61 %29.6 %
201059.09 %26.58 %23.14 %
200963.1 %28.45 %21.45 %
200861.67 %25.45 %20.59 %
200764.93 %23.48 %16.77 %
200668.9 %14.67 %10.67 %
200574.14 %20.32 %14.75 %
200476.46 %21.21 %13.02 %

China Medical System Holdings Aktienanalyse

What does China Medical System Holdings do?

China Medical System Holdings Ltd is a leading pharmaceutical conglomerate specializing in the development, manufacturing, and marketing of drugs in China. The company was founded in 1995 and is headquartered in Shenzhen. The history of China Medical System began as a small company based in Hong Kong, specializing in the import of drugs from Europe and the United States. In 2004, the company expanded its business into the Chinese market and began marketing products in China. Through a consistent expansion strategy and targeted investments, the company was able to become a major player in the Chinese pharmaceutical market in a short period of time. Today, China Medical System is one of the largest pharmaceutical companies in China with a wide portfolio of products and services. China Medical System's business model is focused on marketing drugs in China. The company works closely with its international partners and licenses their products for the Chinese market. In addition, China Medical System has its own research and development departments that work on developing new drugs for the Chinese market. The various divisions of China Medical System encompass a wide range of products and services. The company operates in the areas of preparative chemistry, clinical development, pharmaceutical distribution, and marketing. The company also offers services such as clinical trials and other consulting services. Some of China Medical System's most well-known products include the anti-tumor drug Endostar, used for the treatment of lung cancer, and the hepatitis B drug Fufangdanshen. The company has also entered into a number of collaboration agreements with international pharmaceutical companies such as Sanofi and Eli Lilly to market their products in China. Overall, the company has built a strong position in the Chinese market throughout its history and makes significant contributions to the research, development, and marketing of drugs in China. China Medical System Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding China Medical System Holdings's Profit Margins

The profit margins of China Medical System Holdings represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of China Medical System Holdings's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating China Medical System Holdings's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

China Medical System Holdings's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When China Medical System Holdings’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about China Medical System Holdings stock

How much profit has China Medical System Holdings made this year?

China Medical System Holdings has made 1.79 B CNY this year.

How has the profit developed compared to last year?

The profit has increased by -25.54% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does China Medical System Holdings publish its earnings?

China Medical System Holdings publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of China Medical System Holdings?

The profits of China Medical System Holdings are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of China Medical System Holdings?

You can learn more about the earnings of China Medical System Holdings by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does China Medical System Holdings pay?

Over the past 12 months, China Medical System Holdings paid a dividend of 0.62 CNY . This corresponds to a dividend yield of about 8.53 %. For the coming 12 months, China Medical System Holdings is expected to pay a dividend of 0.69 CNY.

What is the dividend yield of China Medical System Holdings?

The current dividend yield of China Medical System Holdings is 8.53 %.

When does China Medical System Holdings pay dividends?

China Medical System Holdings pays a quarterly dividend. This is distributed in the months of June, June, September, September.

How secure is the dividend of China Medical System Holdings?

China Medical System Holdings paid dividends every year for the past 17 years.

What is the dividend of China Medical System Holdings?

For the upcoming 12 months, dividends amounting to 0.69 CNY are expected. This corresponds to a dividend yield of 9.58 %.

In which sector is China Medical System Holdings located?

China Medical System Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Medical System Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Medical System Holdings from 9/9/2024 amounting to 0.02 CNY, you needed to have the stock in your portfolio before the ex-date on 8/30/2024.

When did China Medical System Holdings pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of China Medical System Holdings in the year 2023?

In the year 2023, China Medical System Holdings distributed 0.616 CNY as dividends.

In which currency does China Medical System Holdings pay out the dividend?

The dividends of China Medical System Holdings are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Medical System Holdings

Our stock analysis for China Medical System Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Medical System Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.